Increased arterial stiffness assessed by pulse wave velocity in Behçet's disease and its association with the lipid profile

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 4, 2013, Pages 454-459

  Caldas, C A M ^a   Borba, E F ^a   Bortolotto, L A ^a   Medeiros, D M ^a   Bonfa, E ^a   Goncalves C R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; BEHCET DISEASE; BLOOD VESSEL DIAMETER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART RATE; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PULSE WAVE; STRAIN GAUGE TRANSDUCER; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BEHCET SYNDROME; CAROTID ARTERIES; FEMALE; HUMANS; LIPIDS; MALE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84875371119     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04458.x     Document Type: Article

References (34)

1. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study. Br J Dermatol 2007; 157: 901-906.
2. Keser G, Aksu K, Tamsel S, et al. Increased thickness of the carotid artery intima-media assessed by ultrasonography in Behçet's disease. Clin Exp Rheumatol 2005; 23: S71-S76.
3. Matsumoto T, Uekusa T, Fukuda Y,. Vasculo-Behçet's disease: a pathologic study of eight cases. Hum Pathol 1991; 22: 45-51.
4. Kural-Seyahi E, Fresko I, Ozyazgan Y, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine 2003; 82: 60-76.
5. O'Duffy JD,. Vasculitis in Behçet's disease. Rheum Dis Clin North Am 1990; 16: 423-431.
6. Tunaci A, Berkmen YM, Gökmen E,. Thoracic involvement in Behçet's disease: pathologic, clinical, and imaging features. Am J Roentgenol 1995; 164: 51-56.
7. Rhee MY, Chang HK, Kim SK,. Intima-media thickness and arterial stiffness of carotid artery in Korean patients with Behçet's disease. J Korean Med Sci 2007; 22: 387-392.
8. Haznedaroǧlu IC, Özcebe OI, Özdemir O, et al. Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med 1996; 240: 181-187.
9. Ozdemir R, Barutcu I, Sezgin AT, et al. Vascular endothelial function and plasma homocysteine levels in Behçet's disease. Am J Cardiol 2004; 94: 522-525.
10. Hansen TW, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-670.
11. Kürüm T, Yildiz M, Soy M, et al. Arterial distensibility as determined by carotid-femoral pulse wave velocity in patients with Behçet's disease. Clin Rheumatol 2005; 24: 134-138.
12. Chang HK, Kim SK, Lee SS, Rhee MY,. Arterial stiffness in Behçet's disease: increased regional pulse wave velocity values. Ann Rheum Dis 2006; 65: 415-416.
13. Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans. Am J Hypertens 2002; 15: 743-753.
14. Alan S, Ulgen MS, Akdeniz S, et al. Intima-media thickness and arterial distensibility in Behçet's disease. Angiology 2004; 55: 413-419.
15. Oflaz H, Mercanoglu F, Karaman O, et al. Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract 2005; 59: 777-781.
16. Öztürk MA, Oktar SO, Ünverdi S, et al. Morphologic evidence of subclinical atherosclerosis obtained by carotid ultrasonography in patients with Behçet's disease. Rheumatol Int 2006; 26: 867-872.
17. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Behçet's syndrome. Semin Arthritis Rheum 2008; 38: 1-12.
18. Caliskan M, Gullu H, Yilmaz S, et al. Cardiovascular prognostic value of vascular involvement in Behcet's disease. Int J Cardiol 2008; 125: 428-430.
19. Wechsler B, Davatchi F, Hamza M, et al. Criteria for diagnosis of Behçet's disease-International Study Group for Behçet's disease. Lancet 1990; 335: 1078-1080.
20. Lawton G, Bhakta BB, Chamberlain MA, Tennant A,. The Behçet's disease activity index. Rheumatology 2004; 43: 73-78.
21. Neves FS, Moraes JCB, Kowalski SC, et al. Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 2007; 26: 1263-1267.
22. Fridewald WT, Levy RI, Frederickson DS,. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 8: 499-502.
23. Paini A, Boutouyrie P, Calvet D, et al. Carotid and aortic stiffness: determinants and discrepancies. Hypertension 2006; 47: 371-376.
24. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26: 485-490.
25. Hoeks AP, Willekes C, Boutouyrie P, et al. Automated detection of local artery wall thickness based on M-line signal processing. Ultrasound Med Biol 1997; 23: 1017-1023.
26. Hong SN, Park JC, Yoon NS, et al. Carotid artery intima-media thickness in Behcet's disease patients without significant cardiovascular involvement. Korean J Intern Med 2008; 23: 87-93.
27. Lie JT,. Vascular involvement in Behçet's disease: arterial and venous and vessels of all sizes. J Rheumatol 1992; 19: 341-343.
28. Örem A, Yandi YE, Vanizor B, et al. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. Clin Biochem 2002; 35: 217-224.
29. Henkin Y, Como JA, Oberman A,. Secondary dyslipidemia. Inadvertent effects of drugs in clinical practice. JAMA 1992; 267: 961-968.
30. Leiba M, Seligsohn U, Sidi Y, et al. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004; 63: 1445-1449.
31. Doggen CJM, Smith NL, Lemaitre RN, et al. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol 2004; 24: 1970-1975.
32. Kawasaki T, Kambayashi J, Ariyoshi H, et al. Hypercholesterolemia as a risk factor for deep-vein thrombosis. Thromb Res 1997; 88: 67-73.
33. Kayikçioǧlu M, Aksu K, Hasdemir C, et al. Endothelial functions in Behçet's disease. Rheumatol Int 2006; 26: 304-308.
34. Orem A, Efe H, Deǧer O, Cimşit G, Uydu HA, Vanizor B,. Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. J Dermatol Sci 1997; 16: 11-16.